Polymerized estrogen provides neuroprotection in preclinical testing
Biomaterial developed at Rensselaer shows promise as spinal cord injury treatment
2021-03-19
(Press-News.org) TROY, N.Y. -- A novel form of polymerized estrogen developed at Rensselaer Polytechnic Institute can provide neuroprotection when implanted at the site of a spinal cord injury -- preventing further damage. This promising result, found in a preclinical model, was recently published in ACS Chemical Neuroscience, and it lays the groundwork for further advancement of this new biomaterial.
"What we saw that gives us hope is more neuroprotection, meaning we saw more spared neurons and more spared axons in the tissue," said Ryan Gilbert, a professor of biomedical engineering at Rensselaer, and co-author on this paper. "We believe that the estrogen released from our biomaterial design is providing a neuroprotective response."
After a spinal cord injury, the body's inflammatory response can cause further damage to nervous system cells -- like a loss of neurons and axons -- even beyond the site of initial injury. A solution that could prevent additional deterioration, or even promote regeneration over time, could be a paradigm shift in treatment. Estrogen is a natural hormone produced within the body. When polymerized, it shows promise as a source of neuroprotection following a spinal cord injury.
Gilbert, a member of the Center for Biotechnology and Interdisciplinary Studies at Rensselaer, collaborated with Edmund Palermo, an associate professor of materials science and engineering at Rensselaer, to design this polymer. The preclinical aspect was initiated by Manoj Gottipati, a Rensselaer research associate, currently working in the laboratory of Phillip Popovich, professor and chair of the Department of Neuroscience at The Ohio State University. At Ohio State, Gottipati worked with Zhen Guan from the Center for Brain and Spinal Cord Repair to test the polymerized estrogen film. The researchers observed enhanced neuroprotection in a preclinical mouse model that had the implanted polymerized estrogen when compared to models that did not receive this treatment.
The polymer itself is entirely made of estrogen, which is released slowly within the body over time as water reactions break down the bonds that hold the polymer chain together, making it a unique and promising therapeutic approach.
"Since the drug molecule is enchained in every repeating unit of the long chain, it contains a very high drug load compared to conventional delivery approaches," said Palermo, who is also co-author on this paper and a member of the Rensselaer Center for Materials, Devices, and Integrated Systems.
According to Palermo, the polymer studied in this research is one of a number of candidates the researchers will continue to investigate as they work to find the optimal release rate for enhanced neuroprotection. Finely tuning hydrophobicity, mechanical properties, and hydrolysis rates could all make a difference in critical aspects of its performance, such as how quickly the polymer releases estrogen within the body.
"All of those factors will play a role in the complex cascade of biochemical and biophysical events that occur during the course of the body's reaction to spinal cord injury," Palermo said.
As the team continues to modify this biomaterial, what researchers develop could have implications beyond spinal cord injury therapeutics.
"I would say that this approach could be used for any sort of central nervous system injury, from spinal cord to brain injury," Gilbert said. "Anything where we could inject or place it near the injury site and have that therapy be released for an extended duration."
INFORMATION:
About Rensselaer Polytechnic Institute
Founded in 1824, Rensselaer Polytechnic Institute is America's first technological research university. Rensselaer encompasses five schools, 32 research centers, more than 145 academic programs, and a dynamic community made up of more than 7,600 students and over 100,000 living alumni. Rensselaer faculty and alumni include more than 145 National Academy members, six members of the National Inventors Hall of Fame, six National Medal of Technology winners, five National Medal of Science winners, and a Nobel Prize winner in Physics. With nearly 200 years of experience advancing scientific and technological knowledge, Rensselaer remains focused on addressing global challenges with a spirit of ingenuity and collaboration. To learn more, please visit http://www.rpi.edu.
ELSE PRESS RELEASES FROM THIS DATE:
2021-03-19
The results showed that several psychological well-being measures gradually increased within participants from the beginning to the end of the course. That was especially true for life satisfaction, perceived well-being, self-awareness and emotional self-regulation. The participants in the study also reported a significant decrease in anxiety, perceived stress, negative thoughts, rumination and anger tendencies. The researchers observed, simultaneously, improvements in the positive aspects and a reduction of negative emotions, both in the short term and longitudinally ...
2021-03-19
UNIVERSITY PARK, Pa. -- Stress is a universal human experience that almost everyone deals with from time to time. But a new study found that not only do some people report feeling no stress at all, but that there may be downsides to not experiencing stress.
The researchers found that people who reported experiencing no stressors were more likely to experience better daily well-being and fewer chronic health conditions. However, they were also more likely to have lower cognitive function, as well.
David M. Almeida, professor of human development and family studies at Penn State, said the study suggests that small, daily stressors could potentially benefit the brain, despite being an inconvenience.
"It's possible that experiencing stressors creates opportunities for you ...
2021-03-19
Three University of Colorado Cancer Center researchers are part of a team that recently published a paper offering new insight into how the immune system relates to cancer. Quentin Vicens, PhD, Jeffrey Kieft, PhD, and Beat Vögeli, PhD, are authors on the paper, which looks at how an enzyme called ADAR1 operates in pathways associated with cancer.
"In a cell, ADAR1 edits native RNA -- or self-RNA -- so that the cell recognizes it as its own. It's a key protection against autoimmune disorders," Kieft says. "But if a virus infects, viral RNA isn't edited by ADAR1, so the cell can recognize that and react. The cell knows it has foreign RNA, and it activates immune responses to fight off that infection."
For their paper published last month in the ...
2021-03-19
Nearly two-thirds of middle-aged and older adults in Canada report adverse childhood experiences
Hamilton, ON (Mar. 19, 20121) - New research from McMaster University has found that roughly three in every five Canadian adults aged 45 to 85 have been exposed to childhood abuse, neglect, intimate partner violence or other household adversity.
The research, which estimates the prevalence of a broad range of adverse childhood experiences, was published in CMAJ Open.
"Our research showed that adverse childhood experiences are highly prevalent in the Canadian population, with 62% of Canadian adults aged 45 to 85 reporting at least one exposure," said Divya Joshi, the study's lead author and a postdoctoral fellow in the Department ...
2021-03-19
In 1961, physicist Ugo Fano provided the first theoretical explanation to an anomalous asymmetry observed in the spectral profiles of noble gases. He put forth an impactful interpretation of this phenomenon, now called "Fano resonance," stating that if a discrete excited state of a system falls within the energy range of a continuum of other possible states, these two can interfere with each other and give rise to abnormal peaks and dips in the system's frequency response.
Though Fano resonance can occur in various physical systems, recent progress in metasurfaces and nanotechnology has drawn attention to this phenomenon as a potentially powerful tool in optics. ...
2021-03-19
The Research Group on Synthetic Biology for Biomedical Applications at Pompeu Fabra University in Barcelona, Spain, has designed a cellular device capable of computing by printing cells on paper. For the first time, they have developed a living device that could be used outside the laboratory without a specialist, and it could be produced on an industrial scale at low cost. The study is published in Nature Communications and was carried out by Sira Mogas-Díez, Eva Gonzalez-Flo and Javier Macía.
We currently have many electronic devices available to us such as computers and tablets whose computing power is highly efficient. But, despite their ...
2021-03-19
DALLAS, March 19, 2021 -- Mechanical removal of blood clots causing a stroke is increasing, yet racial differences in treatment persist, according to late-breaking science presented today at the American Stroke Association's International Stroke Conference 2021. The virtual meeting is March 17-19, 2021 and is a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health.
Mechanical clot-removal or endovascular therapy is a non-surgical treatment that uses tiny tubes, or catheters, to remove a blood clot. In 2015, several major clinical trials confirmed that endovascular therapy ...
2021-03-19
In Brazil, researchers affiliated with the Center for Nuclear Energy in Agriculture (CENA) and the Luiz de Queiroz College of Agriculture (ESALQ), both part of the University of São Paulo (USP), have developed a methodology based on artificial intelligence to automate and streamline seed quality analysis, a process required by law and currently done manually by analysts accredited with the Ministry of Agriculture.
The group used light-based technology like that deployed in plant and cosmetics analysis to acquire images of the seeds. They then turned to machine learning to automate the image interpretation ...
2021-03-19
DALLAS, March 19, 2021 -- New research found patients hospitalized with COVID-19 had a higher risk of stroke, compared with patients who had similar infectious conditions such as influenza and sepsis in prior studies. Those who had an ischemic stroke were more likely to be older, male, Black race, or have high blood pressure, Type 2 diabetes or an irregular heartbeat (atrial fibrillation) compared with other COVID-19 patients, according to late-breaking science presented today at the American Stroke Association's International Stroke Conference 2021. The meeting is being held virtually, March 17-19, 2021 and is a world premier meeting for researchers and clinicians dedicated ...
2021-03-19
Schizophrenia and personality disorders are the most disabling mental health conditions to live with, according to scientists from The University of Queensland.
A Danish-Australian research team studied a cohort of 6.9 million Danish residents in the Danish Psychiatric Central Research Register to understand the burden of disability associated with 18 mental and substance use disorders.
Professor John McGrath from UQ Queensland Brain Institute's and the Queensland Centre for Mental Health Research said the data was used to develop a new method for measuring disability that took comorbidities into account.
"Traditionally the impact of mental disorders has been presented for an entire nation, ...
LAST 30 PRESS RELEASES:
[Press-News.org] Polymerized estrogen provides neuroprotection in preclinical testing
Biomaterial developed at Rensselaer shows promise as spinal cord injury treatment
